The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy

Published:2016-07-01 Issue:7 Volume:2 Page:929
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Mittendorf Elizabeth A.¹,Vila Jose¹,Tucker Susan L.²,Chavez-MacGregor Mariana³,Smith Benjamin D.⁴,Symmans W. Fraser⁵,Sahin Aysegul A.⁵,Hortobagyi Gabriel N.⁶,Hunt Kelly K.¹

Affiliation:

1. Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston

2. Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston

3. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston4Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston

4. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston

5. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston

6. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluctuations in serum lipid levels during neoadjuvant treatment as novel predictive and prognostic biomarkers for locally advanced breast cancer: a retrospective analysis based on a prospective cohort;Lipids in Health and Disease;2024-08-22

2. Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer;Current Treatment Options in Oncology;2024-08-15

3. Circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers combined with clinicopathological risk has potential to better predict recurrence in stage III breast cancer treated with neoadjuvant chemotherapy: a pilot study;Breast Cancer Research and Treatment;2024-07-11

4. Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy for Triple Negative Breast Cancer;Annals of Surgical Oncology;2024-06-13

5. Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy;European Journal of Cancer;2024-05